
Adamant Health’s technology is based on research
Filter by category: Parkinson’s disease | Epilepsy | All

Detecting negative myoclonus during long-term home measurements using wearables
Clinical Neurophysiology, 2023:156:166–174 – A. Sinokki, L. Säisänen, J. Hyppönen, K. Silvennoinen, R. Kälviäinen, E. Mervaala, P. Karjalainen, S. Rissanen

Positive and negative myoclonus monitoring using ambulatory surface EMG and 3D accelerometry
International Parkinson and Movement Disorder Society 2023 International Congress; 38 (suppl 1), Abstract number 1792 – S. Rissanen, A. Sinokki, J. Hyppönen, L. Säisänen, K. Silvennoinen, P. Karjalainen, E. Mervaala, Z. Hadj-Allal, R. Kälviäinen

Changes in elbow flexion EMG morphology during adjustment of deep brain stimulator in advanced Parkinson’s disease
PLOS ONE 2022:17(4): e0266936 – V. Ruonala, E. Pekkonen, O. Airaksinen, M. Kankaanpää, P. Karjalainen, S. Rissanen

Surface electromyography and kinematic measurements in Parkinson’s disease: analysis methods for differential diagnosis and quantification of treatment
Publications of the University of Eastern Finland. Dissertations in Forestry and Natural Sciences 2022, no. 463 – V. Ruonala
Newsletter
Be the first to know about our new technology, events & other updates.